Zacur HA. Epidemiology, clinical manifestations, and pathophysiology of polycystic ovary syndrome. Adv Stud Med. 2003;3(8A):S733–9.

Google Scholar 

Azziz R, Carmina E, Chen Z, Dunaif A, Laven JSE, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2(1):16057.

Article  PubMed  Google Scholar 

Sourinejad H, Savabi Esfahani M, Tarrahi MJ, Adib Moghaddam E. Outcomes and challenges associated with in vitro fertilization in women with polycystic ovary syndrome: A review study. J Sabzevar Univ Med Sci. 2021;28(3):359–71.

Google Scholar 

Keikha F, Tehraninejad ES, Rakhshkhorshid M, Afiat M, Hagholahi F, Ghasemi F. The association of the betatrophin level with metabolic and inflammatory parameters in infertile women with polycystic ovary syndrome: A case-control study. Int J Reprod Biomed. 2022;20(1):29.

CAS  PubMed  PubMed Central  Google Scholar 

Elkoça A, Özcan H, Kahraman BY. Complementary and alternative medicine therapies used by women with polycystic ovary syndrome. Adv Integr Med. 2024;12(1):75–80.

Article  Google Scholar 

Khan F, Maharaj M, Govender N, Thandar Y. Management of polycystic ovarian syndrome: a qualitative inquiry among complementary and alternative medicine practitioners in South Africa. Homeopathy. 2025;114(01):032–43.

Article  Google Scholar 

Mohammed S, Cockburn BN, Sundaram V. Exploring the novel alternative and modern treatment options for polycystic ovary syndrome– a review. Integr Med Rep. 2024;3(1):33–42.

Article  CAS  Google Scholar 

Patel A, Jacob A, Thomas R. A comprehensive review on treatments for polycystic ovarian syndrome (PCOS). Nur Prim Care. 2024;8(1):1–17.

Google Scholar 

Siddique R, Mehmood MH. Role of complementary and alternative medicine in polycystic ovary syndrome. In: Rehman R, Sheikh A, editors. Polycystic ovary syndrome. New Delhi: Elsevier; 2024. pp. 171–80.

Sha Y, Zhu J, Shen F. A meta-analysis of efficacy on dexamethasone and clomiphene in the treatment of polycystic ovary syndrome patients. BMC Womens Health. 2024;24(1):298.

Article  PubMed  PubMed Central  Google Scholar 

Rhen T, Cidlowski JA. Anti inflammatory action of glucocorticoids– New mechanisms for old drugs. N Engl J Med. 2005;353(16):1711–23.

Article  CAS  PubMed  Google Scholar 

Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review. Hum Reprod Update. 2002;8(6):559–77.

Article  CAS  PubMed  Google Scholar 

Vanky E, Salvesen K, Carlsen S. Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and Metformin. Hum Reprod. 2004;19(3):529–33.

Article  CAS  PubMed  Google Scholar 

Harlow CR, Jenkins JM, Winston RM. Increased follicular fluid total and free cortisol levels during the luteinizing hormone surge. Fert Steril. 1997;68(1):48–53.

Article  CAS  Google Scholar 

Basirat Z, Zeinalzadeh M, Mahouti T, Golsorkhtabaramiri M. Impact of dexamethasone on pregnancy outcome in PCOs women candidate for IVF/ICSI, a single-blind randomized clinical trial study. Middle East Fertil Soc J. 2016;21(3):184–8.

Article  Google Scholar 

Ashrafi M, Zafarani F, Shahrokh Tehraninejad E, Baghestani AR, Amirchaghmaghi E. Dexamethasone as a supplement for exogenous gonadotropin to improve ovarian response of women over 35 years undergoing IVF/ICSI cycles. Iran J Fertil Steril. 2007;1(2):69–74.

Google Scholar 

Keay SD, Lenton EA, Cooke ID, Hull MGR, Jenkins JM. Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme. Hum Reprod. 2001;16(9):1861–5.

Article  CAS  PubMed  Google Scholar 

Zhang D, Wu X, Jiang A-f, Yang T, Zhao S, Wang L et al. Prednisone enhances pregnancy outcomes in gonadotropin-releasing hormone antagonist protocol: A multi-center randomized clinical trial. medRxiv. 2024:2024.10.11.24315288.

Liu S, Shi L, Wang T, Shi J. Effect of low-dose dexamethasone on patients with elevated early follicular phase progesterone level and pregnancy outcomes in IVF-ET treatment: A randomized controlled clinical trial. Clin Endocrinol. 2018;89(6):771–8.

Article  CAS  Google Scholar 

Lin L, Li T, Chen L, Sha C, Gao W, Wei H, et al. Glucocorticoid supplementation during ovulation induction for assisted reproductive technology: A systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2023;36(2):2227310.

Article  PubMed  Google Scholar 

Farzaneh F, Afshar F. Comparison of ovulation induction with letrozole plus dexamethasone and letrozole alone in infertile women with polycystic ovarian disease: an RCT. Int J Reprod Biomed. 2020;18(4):307.

CAS  PubMed  PubMed Central  Google Scholar 

Bider D, Amoday I, Tur-Kaspa I, Livshits A, Dor J, Endocrinology. The addition of a glucocorticoid to the protocol of programmed oocyte retrieval for in-vitro fertilization– a randomized study. Hum Reprod. 1996;11(8):1606–8.

Article  CAS  PubMed  Google Scholar 

Bider D, Hourvitz A, Tur Kaspa I, Dirnfeld M, Dor J. Dexamethasone supplementation to gonadotropin stimulation for in vitro fertilization in polycystic ovarian disease. J Assist Reprod Genet. 1999;16:233–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rein MS, Jackson KV, Sable DB, Thomas PP, Hornstein MD. Dexamethasone during ovulation induction for in-vitro fertilization: A pilot study. Hum Reprod. 1996;11(2):253–5.

Article  CAS  PubMed  Google Scholar